广济药业：2'-岩藻糖基乳糖行政许可申请获批

Core Viewpoint - Guangji Pharmaceutical (000952) has received approval from the National Health Commission for its application of 2'-fucosyllactose, a significant step towards the product's industrialization [1] Group 1: Product Approval - The application for 2'-fucosyllactose has passed the administrative review and has been officially announced [1] - 2'-fucosyllactose is a oligosaccharide abundant in breast milk, known for its benefits in regulating gut microbiota, promoting brain development, and enhancing immunity [1] - The product is included in the list of food nutrition fortifiers, allowing its use in infant formula and milk powder [1] Group 2: Research and Development - The successful approval of 2'-fucosyllactose is a result of the company's independent research and development efforts [1] - The approval meets national technical review standards, laying a solid foundation for the company's advancement in product industrialization [1]